Literature DB >> 10398486

The Structure of the Human Placenta: Implications for Initiating and Defending Against Virus Infections.

.   

Abstract

The architecture of the human placenta permits an extensive and intimate association between the maternal and fetal circulations. The fetal component consists of the elaborately branched villous tree, and this is bathed directly by maternal blood circulating within the intervillous space. Whilst this arrangement may favour metabolic exchange, it poses considerable risks for the vertical transmission of pathogens. Some features of placental structure can be considered potential impediments to transmission, such as the syncytial nature of the outer villous covering, the syncytiotrophoblast, and the ability of this tissue to secrete both nitric oxide and interferons. Other features may facilitate vertical transmission, including the lack of expression of MHC Class 1 antigens by the syncytiotrophoblast, and its vesicular and immunoglobulin transport pathways. More importantly, it is known that physical defects occur in the trophoblast layers at all stages in gestation. Whilst repair processes have been identified it must be assumed that pathogens or infected maternal white cells have access to the trophoblastic basement membrane, albeit transiently. The universal nature of these defects suggests that the trophoblast cannot be of paramount importance in the prevention of transmission. Rather, the defence mechanisms must lie either at the level of the basement membrane or within the villous core. There they may be represented by the resident macrophage population or the capillary endothelial cells and their junctional complexes. Consequently, the placenta should be viewed as an active rather than a passive barrier. Copyright 1997 by John Wiley & Sons, Ltd.

Entities:  

Year:  1997        PMID: 10398486     DOI: 10.1002/(sici)1099-1654(199712)7:4<219::aid-rmv205>3.0.co;2-e

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  17 in total

1.  Placenta-on-a-chip: a novel platform to study the biology of the human placenta.

Authors:  Ji Soo Lee; Roberto Romero; Yu Mi Han; Hee Chan Kim; Chong Jai Kim; Joon-Seok Hong; Dongeun Huh
Journal:  J Matern Fetal Neonatal Med       Date:  2015-06-15

Review 2.  The placenta: a multifaceted, transient organ.

Authors:  Graham J Burton; Abigail L Fowden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

Review 3.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches.

Authors:  Rajeendra L Pemathilaka; David E Reynolds; Nicole N Hashemi
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

5.  Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques.

Authors:  Citra N Z Mattar; Amit C Nathwani; Simon N Waddington; Niraja Dighe; Christine Kaeppel; Ali Nowrouzi; Jenny Mcintosh; Nuryanti B Johana; Bryan Ogden; Nicholas M Fisk; Andrew M Davidoff; Anna David; Donald Peebles; Marcus B Valentine; Jens-Uwe Appelt; Christof von Kalle; Manfred Schmidt; Arijit Biswas; Mahesh Choolani; Jerry K Y Chan
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

6.  Polarized release of human cytomegalovirus from placental trophoblasts.

Authors:  D G Hemmings; L J Guilbert
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism.

Authors:  Han Bai; Lin Zhang; Li Ma; Xiao-Guang Dou; Guo-He Feng; Gui-Zhen Zhao
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

8.  Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

Authors:  A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

9.  Single-cell reconstruction of the early maternal-fetal interface in humans.

Authors:  Roser Vento-Tormo; Mirjana Efremova; Muzlifah Haniffa; Ashley Moffett; Sarah A Teichmann; Rachel A Botting; Margherita Y Turco; Miquel Vento-Tormo; Kerstin B Meyer; Jong-Eun Park; Emily Stephenson; Krzysztof Polański; Angela Goncalves; Lucy Gardner; Staffan Holmqvist; Johan Henriksson; Angela Zou; Andrew M Sharkey; Ben Millar; Barbara Innes; Laura Wood; Anna Wilbrey-Clark; Rebecca P Payne; Martin A Ivarsson; Steve Lisgo; Andrew Filby; David H Rowitch; Judith N Bulmer; Gavin J Wright; Michael J T Stubbington
Journal:  Nature       Date:  2018-11-14       Impact factor: 69.504

10.  Proteasome-independent degradation of HIV-1 in naturally non-permissive human placental trophoblast cells.

Authors:  Anna Laura Ross; Claude Cannou; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  Retrovirology       Date:  2009-05-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.